Expeditors International of Washington Operating Cash Flow increased by 9.2% to $309.23M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 9.7%, from $342.62M to $309.23M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 3.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $30.30M | $177.37M | $305.00M | $413.95M | $558.65M | $670.38M | $486.70M | $546.41M | $158.45M | $189.98M | $158.35M | $256.90M | $126.77M | $89.97M | $249.72M | $342.62M | $179.21M | $201.37M | $283.30M | $309.23M |
| QoQ Change | — | +485.4% | +72.0% | +35.7% | +35.0% | +20.0% | -27.4% | +12.3% | -71.0% | +19.9% | -16.6% | +62.2% | -50.7% | -29.0% | +177.5% | +37.2% | -47.7% | +12.4% | +40.7% | +9.2% |
| YoY Change | — | — | — | — | >999% | +278.0% | +59.6% | +32.0% | -71.6% | -71.7% | -67.5% | -53.0% | -20.0% | -52.6% | +57.7% | +33.4% | +41.4% | +123.8% | +13.4% | -9.7% |